Blackstone Inc.
BXNYSEInvestment AdviceFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 11/307% above fair value
$120.14+1.63 (+1.38%)
Close on Nov 2, 2026Market cap $90.18BP/E 26.9Yield 3.90%
Blackstone Life Sciences (BXLS) — NAPR: $216M in FY2025, up 9.6% from a year earlier.
Latest, FY2025
216
Period ended Dec 31, 2025
Change on a year earlier
+9.6%
197 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Where the FY2025 figure comes from
Source: Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-04-23, filed 2026-04-23) ↗
Reported in BX Form 8-K EX-99.1 (NAPR, Deconsolidated Balance Sheet & Share Summary).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Life Sciences (BXLS) — NAPR ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 216 | +9.6% | Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-04-23, filed 2026-04-23) ↗ |
| FY2024 | Dec 31, 2024 | 197 | +140.2% | Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-01-29, filed 2026-01-29) ↗ |
| FY2023 | Dec 31, 2023 | 82 | +228.0% | Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2025-01-30, filed 2025-01-30) ↗ |
| FY2022 | Dec 31, 2022 | 25 | +19.0% | Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2024-01-25, filed 2024-01-25) ↗ |
| FY2021 | Dec 31, 2021 | 21 | +110.0% | Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2023-01-26, filed 2023-01-26) ↗ |
| FY2020 | Dec 31, 2020 | 10 | – | Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2022-01-27, filed 2022-01-27) ↗ |
Cite this data
StockData. (2026). Blackstone Life Sciences (BXLS) — NAPR ($M), annual FY2020–FY2025 [Data set]. Compiled from Blackstone SEC filings and investor materials. https://stockdatahq.com/stocks/bx/kpis/napr-bxls-row
See every metric in the Blackstone KPI table. Data updated Nov 1, 2026.